# Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

> **NCT06405178** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beni-Suef University** · enrollment: 500 (estimated)

## Conditions studied

- Polycystic Ovary

## Interventions

- **DRUG:** Metformin
- **DRUG:** Dapagliflozin
- **DRUG:** Dapagliflozin/Metformin
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT06405178
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06405178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06405178, "Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06405178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*